|
|
International Journal of Pediatrics، جلد ۲، شماره ۲.۳، صفحات ۷۳-۷۳
|
|
|
| عنوان فارسی |
|
|
| چکیده فارسی مقاله |
|
|
| کلیدواژه‌های فارسی مقاله |
|
|
| عنوان انگلیسی |
Genetically Engineered Mouse Embryonic Stem Cell – derived Cardiomyocytes as a Suitable Model on Drugs Toxicity In vitro |
|
| چکیده انگلیسی مقاله |
Background DOX is a powerful chemotherapeutic agent used in the treatment of solid tumors and malignant hematological diseases. However, its cardiac toxicity limits the clinical usefulness of this drug. Previous reports have shown Corticosteroids induce a cytoprotective effect on cardiomyocytes. Mouse transgenic embryonic stem cell-derived pure cardiomyocytes may be considered as a model for assessment pharmacological and toxicological effects of drugs in vitro. Methods Mouse transgenic embryonic stem cell-derived pure cardiomyocytes were treated by different concentrations of doxorubicin to determine DOX LD50. Pure cardiomyocytes were evaluated in two groups: treatment by 10µM DEX 24 h before or before and in continuation with DOX. The percentage of cardiomyocyte viability by MTS assay, the percentage of beating and quantitative Real Time polymerase chain reaction (Real Time-PCR) for cardiac gene expression (β-MHC) was evaluated in each group. Results 5µM DOX was determined as drug concentration that leads to 50% cardiomyocyte mortality. Cardiotoxicity on mouse transgenic embryonic stem cell-derived pure cardiomyocytes can be ameliorated by treatment with dexamethasone (DEX) when DEX administrated before DOX. The effect of DEX appears to be mediated via glucocorticoid receptors. DEX increases cardiomyocyte gene expression and decreases apoptosis. Conclusion Transgenic embryonic stem cell derived cardiomyocytes are a model for evaluation of doxorubicin toxicity. Additionally, this model provides us with a clinical suggestion, which proposes that the beneficial effect of DEX is obtained when DEX was added only before DOX. Also the results of present study were consistent with in vivo result in mice. Key words: Apoptosis, Cardiotoxicity, Doxorubicin, Mouse Transgenic Embryonic Stem Cell. |
|
| کلیدواژه‌های انگلیسی مقاله |
poster presentation |
|
| نویسندگان مقاله |
لیلا دهقانی | leila dehghani
isfahan neurosciences research centre, isfahan university of medical sciences, isfahan, iran.
سازمان اصلی تایید شده: دانشگاه علوم پزشکی اصفهان (Isfahan university of medical sciences)
محمد حسین نصر اصفهانی | mohammad hossein nasr esfahani
department of cell and molecular biology, cell science research center, royan institute for animal biotechnology, acecr , isfahan, iran.
سازمان اصلی تایید شده: پژوهشگاه رویان (Royan institute)
سهیلا طحانی | soheila tahani
department of medical sciences, islamic azad university, najafabad branch, isfahan, iran.
سازمان اصلی تایید شده: دانشگاه آزاد اسلامی علوم و تحقیقات (Islamic azad university science and research branch)
|
|
| نشانی اینترنتی |
http://ijp.mums.ac.ir/article_2736.html |
| فایل مقاله |
فایلی برای مقاله ذخیره نشده است |
| کد مقاله (doi) |
|
| زبان مقاله منتشر شده |
en |
| موضوعات مقاله منتشر شده |
|
| نوع مقاله منتشر شده |
|
|
|
|
برگشت به:
صفحه اول پایگاه |
نسخه مرتبط |
نشریه مرتبط |
فهرست نشریات
|